Marquette Asset Management’s Standard BioTools LAB Stock Holding History

Marquette Asset Management’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$268K	Buy	+325,345	New	+$307K	0.03%	82

Other funds holding LAB

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Marquette Asset Management's LAB Position: Q2 2026 in Review

Marquette Asset Management opened a new position in Standard BioTools (LAB) in Q2 2026: 325,345 shares worth $268K. The stake represents 0.03% of the portfolio and ranks #82 among its holdings.

5 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

Marquette Asset Management held 325,345 shares of Standard BioTools worth $268K as of Q2 2026.
Standard BioTools was a new Marquette Asset Management position in Q2 2026.
Standard BioTools made up 0.03% of Marquette Asset Management's portfolio in Q2 2026, its #82 holding.
5 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.